201 related articles for article (PubMed ID: 27750350)
1. A Neutral Effect of Metformin Treatment on Macroprolactin Content in Women with Macroprolactinemia.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):223-228. PubMed ID: 27750350
[No Abstract] [Full Text] [Related]
2. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
[TBL] [Abstract][Full Text] [Related]
3. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
4. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and reproductive manifestations of macroprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
[TBL] [Abstract][Full Text] [Related]
7. A neutral effect of testosterone therapy on macroprolactin content in men with macroprolactinemia and late-onset hypogonadism.
Krysiak R; Kowalska B; Szkróbka W; Okopień B
Pharmacol Rep; 2016 Feb; 68(1):139-43. PubMed ID: 26721365
[TBL] [Abstract][Full Text] [Related]
8. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):22-28. PubMed ID: 31234219
[TBL] [Abstract][Full Text] [Related]
10. Sex-Dependent Effect of Metformin on Serum Prolactin Levels In Hyperprolactinemic Patients With Type 2 Diabetes: A Pilot Study.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2018 Jun; 126(6):342-348. PubMed ID: 29169197
[TBL] [Abstract][Full Text] [Related]
11. Serum prolactin and macroprolactin levels in diabetic nephropathy.
Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R
Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335
[TBL] [Abstract][Full Text] [Related]
12. The association between macroprolactin levels and vitamin D status in premenopausal women with macroprolactinemia: a pilot study.
Krysiak R; Kowalska B; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):446-50. PubMed ID: 26179930
[TBL] [Abstract][Full Text] [Related]
13. Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study.
Krysiak R; Drosdzol-Cop A; Skrzypulec-Plinta V; Okopien B
Endocrine; 2016 Jul; 53(1):291-8. PubMed ID: 26902871
[TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):7-13. PubMed ID: 31185509
[TBL] [Abstract][Full Text] [Related]
15. [Hyperprolactinemia].
Müller OA; von Werder K
Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
[No Abstract] [Full Text] [Related]
16. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
Overgaard M; Pedersen SM
Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
[TBL] [Abstract][Full Text] [Related]
17. The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia.
Krysiak R; Kowalcze K; Szkrobka W; Okopien B
Eur J Intern Med; 2016 May; 30():94-98. PubMed ID: 26858210
[TBL] [Abstract][Full Text] [Related]
18. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
Suliman AM; Smith TP; Gibney J; McKenna TJ
Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
[TBL] [Abstract][Full Text] [Related]
19. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
20. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]